Annual FCF
-$10.11 M
+$1.44 M+12.49%
31 December 2023
Summary:
Yield10 Bioscience annual free cash flow is currently -$10.11 million, with the most recent change of +$1.44 million (+12.49%) on 31 December 2023. During the last 3 years, it has fallen by -$1.38 million (-15.79%). YTEN annual FCF is now -338.77% below its all-time high of -$2.31 million, reached on 31 December 2004.YTEN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$574.00 K
+$329.00 K+36.43%
30 June 2024
Summary:
Yield10 Bioscience quarterly free cash flow is currently -$574.00 thousand, with the most recent change of +$329.00 thousand (+36.43%) on 30 June 2024. Over the past year, it has increased by +$2.04 million (+78.01%). YTEN quarterly FCF is now -4315.38% below its all-time high of -$13.00 thousand, reached on 30 September 2006.YTEN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$5.82 M
+$2.52 M+30.25%
30 June 2024
Summary:
Yield10 Bioscience TTM free cash flow is currently -$5.82 million, with the most recent change of +$2.52 million (+30.25%) on 30 June 2024. Over the past year, it has increased by +$5.63 million (+49.17%). YTEN TTM FCF is now -96.62% below its all-time high of -$2.96 million, reached on 31 March 2006.YTEN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.5% | +78.0% | +49.2% |
| 3 y3 years | -15.8% | +71.3% | +34.9% |
| 5 y5 years | -15.0% | +58.0% | +22.2% |
YTEN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -15.8% | +12.5% | at high | +82.2% | at high | +49.7% |
| 5 y | 5 years | -16.1% | +12.5% | at high | +82.4% | at high | +49.7% |
| alltime | all time | -338.8% | +69.3% | -4315.4% | +95.4% | -96.6% | +83.5% |
Yield10 Bioscience Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$574.00 K(-36.4%) | -$5.82 M(-30.2%) |
| Mar 2024 | - | -$903.00 K(-47.8%) | -$8.34 M(-17.5%) |
| Dec 2023 | -$10.11 M(-12.5%) | -$1.73 M(-33.7%) | -$10.11 M(-11.6%) |
| Sept 2023 | - | -$2.61 M(-15.7%) | -$11.45 M(-1.0%) |
| June 2023 | - | -$3.10 M(+15.7%) | -$11.56 M(+4.9%) |
| Mar 2023 | - | -$2.68 M(-12.6%) | -$11.02 M(-4.7%) |
| Dec 2022 | -$11.56 M(+22.4%) | -$3.06 M(+12.4%) | -$11.56 M(+4.9%) |
| Sept 2022 | - | -$2.72 M(+6.5%) | -$11.02 M(+7.0%) |
| June 2022 | - | -$2.56 M(-20.5%) | -$10.30 M(+3.9%) |
| Mar 2022 | - | -$3.22 M(+27.3%) | -$9.92 M(+5.1%) |
| Dec 2021 | -$9.44 M(+8.1%) | -$2.53 M(+26.2%) | -$9.44 M(+5.6%) |
| Sept 2021 | - | -$2.00 M(-7.9%) | -$8.94 M(-0.6%) |
| June 2021 | - | -$2.17 M(-20.6%) | -$8.99 M(-1.6%) |
| Mar 2021 | - | -$2.74 M(+35.3%) | -$9.14 M(+4.7%) |
| Dec 2020 | -$8.73 M(+0.2%) | -$2.02 M(-1.7%) | -$8.73 M(-12.4%) |
| Sept 2020 | - | -$2.06 M(-11.4%) | -$9.97 M(+7.4%) |
| June 2020 | - | -$2.32 M(-0.3%) | -$9.28 M(+6.1%) |
| Mar 2020 | - | -$2.33 M(-28.5%) | -$8.75 M(+0.4%) |
| Dec 2019 | -$8.71 M(-0.9%) | -$3.26 M(+138.3%) | -$8.71 M(+16.5%) |
| Sept 2019 | - | -$1.37 M(-23.8%) | -$7.48 M(-6.1%) |
| June 2019 | - | -$1.79 M(-21.9%) | -$7.96 M(-1.2%) |
| Mar 2019 | - | -$2.30 M(+13.5%) | -$8.06 M(-8.4%) |
| Dec 2018 | -$8.80 M(+7.2%) | -$2.02 M(+9.3%) | -$8.80 M(+1.5%) |
| Sept 2018 | - | -$1.85 M(-2.0%) | -$8.67 M(-2.0%) |
| June 2018 | - | -$1.89 M(-37.7%) | -$8.84 M(+0.4%) |
| Mar 2018 | - | -$3.03 M(+60.2%) | -$8.81 M(+7.3%) |
| Dec 2017 | -$8.21 M(-45.8%) | -$1.89 M(-6.7%) | -$8.21 M(-6.3%) |
| Sept 2017 | - | -$2.03 M(+9.5%) | -$8.76 M(-23.4%) |
| June 2017 | - | -$1.85 M(-23.8%) | -$11.44 M(+4.9%) |
| Mar 2017 | - | -$2.43 M(-0.6%) | -$10.90 M(-28.1%) |
| Dec 2016 | -$15.16 M(-32.7%) | -$2.45 M(-47.9%) | -$15.16 M(-17.3%) |
| Sept 2016 | - | -$4.70 M(+256.8%) | -$18.33 M(+0.8%) |
| June 2016 | - | -$1.32 M(-80.3%) | -$18.18 M(-18.9%) |
| Mar 2016 | - | -$6.69 M(+18.9%) | -$22.42 M(-0.4%) |
| Dec 2015 | -$22.52 M(-8.9%) | -$5.63 M(+23.6%) | -$22.52 M(-1.3%) |
| Sept 2015 | - | -$4.55 M(-18.0%) | -$22.80 M(-1.3%) |
| June 2015 | - | -$5.55 M(-18.2%) | -$23.10 M(+3.0%) |
| Mar 2015 | - | -$6.79 M(+14.8%) | -$22.43 M(-9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$24.71 M(-8.6%) | -$5.91 M(+21.9%) | -$24.71 M(-2.4%) |
| Sept 2014 | - | -$4.85 M(-0.7%) | -$25.32 M(-4.1%) |
| June 2014 | - | -$4.88 M(-46.2%) | -$26.40 M(-4.1%) |
| Mar 2014 | - | -$9.06 M(+38.9%) | -$27.52 M(+1.9%) |
| Dec 2013 | -$27.02 M(-15.9%) | -$6.53 M(+10.0%) | -$27.02 M(-2.8%) |
| Sept 2013 | - | -$5.93 M(-1.2%) | -$27.80 M(-1.6%) |
| June 2013 | - | -$6.00 M(-29.9%) | -$28.26 M(-0.1%) |
| Mar 2013 | - | -$8.56 M(+17.2%) | -$28.28 M(-12.0%) |
| Dec 2012 | -$32.13 M(-1.5%) | -$7.31 M(+14.3%) | -$32.13 M(-4.7%) |
| Sept 2012 | - | -$6.39 M(+6.1%) | -$33.70 M(-4.5%) |
| June 2012 | - | -$6.02 M(-51.5%) | -$35.27 M(-0.2%) |
| Mar 2012 | - | -$12.41 M(+39.8%) | -$35.36 M(+8.4%) |
| Dec 2011 | -$32.63 M(-0.8%) | -$8.88 M(+11.4%) | -$32.63 M(+1.7%) |
| Sept 2011 | - | -$7.96 M(+30.3%) | -$32.08 M(+1.8%) |
| June 2011 | - | -$6.11 M(-36.9%) | -$31.50 M(-4.7%) |
| Mar 2011 | - | -$9.68 M(+16.2%) | -$33.05 M(+0.4%) |
| Dec 2010 | -$32.90 M(+18.5%) | -$8.33 M(+12.8%) | -$32.90 M(+4.3%) |
| Sept 2010 | - | -$7.39 M(-3.5%) | -$31.54 M(-0.5%) |
| June 2010 | - | -$7.65 M(-19.7%) | -$31.69 M(+11.0%) |
| Mar 2010 | - | -$9.53 M(+36.8%) | -$28.55 M(+2.8%) |
| Dec 2009 | -$27.78 M(+44.8%) | -$6.97 M(-7.6%) | -$27.78 M(+13.1%) |
| Sept 2009 | - | -$7.54 M(+67.2%) | -$24.55 M(+3.5%) |
| June 2009 | - | -$4.51 M(-48.5%) | -$23.71 M(+2.6%) |
| Mar 2009 | - | -$8.76 M(+134.1%) | -$23.11 M(+20.4%) |
| Dec 2008 | -$19.19 M(+23.3%) | -$3.74 M(-44.1%) | -$19.19 M(-3.6%) |
| Sept 2008 | - | -$6.70 M(+71.6%) | -$19.91 M(+24.7%) |
| June 2008 | - | -$3.90 M(-19.4%) | -$15.97 M(-2.6%) |
| Mar 2008 | - | -$4.84 M(+8.4%) | -$16.39 M(+5.3%) |
| Dec 2007 | -$15.56 M(+202.4%) | -$4.47 M(+62.2%) | -$15.56 M(+25.2%) |
| Sept 2007 | - | -$2.75 M(-36.3%) | -$12.43 M(+28.3%) |
| June 2007 | - | -$4.32 M(+7.5%) | -$9.69 M(+56.0%) |
| Mar 2007 | - | -$4.02 M(+202.0%) | -$6.21 M(+20.6%) |
| Dec 2006 | -$5.15 M(-17.8%) | -$1.33 M(>+9900.0%) | -$5.15 M(+34.9%) |
| Sept 2006 | - | -$13.00 K(-98.5%) | -$3.82 M(+0.3%) |
| June 2006 | - | -$844.00 K(-71.5%) | -$3.80 M(+28.5%) |
| Mar 2006 | - | -$2.96 M | -$2.96 M |
| Dec 2005 | -$6.26 M(+171.7%) | - | - |
| Dec 2004 | -$2.31 M | - | - |
FAQ
- What is Yield10 Bioscience annual free cash flow?
- What is the all time high annual FCF for Yield10 Bioscience?
- What is Yield10 Bioscience annual FCF year-on-year change?
- What is Yield10 Bioscience quarterly free cash flow?
- What is the all time high quarterly FCF for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly FCF year-on-year change?
- What is Yield10 Bioscience TTM free cash flow?
- What is the all time high TTM FCF for Yield10 Bioscience?
- What is Yield10 Bioscience TTM FCF year-on-year change?
What is Yield10 Bioscience annual free cash flow?
The current annual FCF of YTEN is -$10.11 M
What is the all time high annual FCF for Yield10 Bioscience?
Yield10 Bioscience all-time high annual free cash flow is -$2.31 M
What is Yield10 Bioscience annual FCF year-on-year change?
Over the past year, YTEN annual free cash flow has changed by +$1.44 M (+12.49%)
What is Yield10 Bioscience quarterly free cash flow?
The current quarterly FCF of YTEN is -$574.00 K
What is the all time high quarterly FCF for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly free cash flow is -$13.00 K
What is Yield10 Bioscience quarterly FCF year-on-year change?
Over the past year, YTEN quarterly free cash flow has changed by +$2.04 M (+78.01%)
What is Yield10 Bioscience TTM free cash flow?
The current TTM FCF of YTEN is -$5.82 M
What is the all time high TTM FCF for Yield10 Bioscience?
Yield10 Bioscience all-time high TTM free cash flow is -$2.96 M
What is Yield10 Bioscience TTM FCF year-on-year change?
Over the past year, YTEN TTM free cash flow has changed by +$5.63 M (+49.17%)